Table 5 Progression free survival and overall survival
ITT population (N = 45) | Evaluable population (N = 43) | PR Population (N = 45) | SD Population (N = 45) | |
|---|---|---|---|---|
Median PFS (95 % CI) | 8.2 mo (6–10.8) | 8.2 mo (6–10.8) | 9.96 mo (8.03-17.38) | 6.16 mo (3.9-16.95) |
Median OS (95 % CI) | 36.6 mo (23.8-45.8) | 36.6 mo (23.8-45.8) | 41.48 mo (23.21-NA) | 36.62 mo (17.51-NA) |